Welldoc and Databricks Strengthen Strategic Partnership to Enhance Welldoc’s AI-Driven Personalized Cardiometabolic Digital Health Solutions

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leading digital health company pioneering AI-driven cardiometabolic care, and Databricks, the Data and AI company, today announced the expansion of their strategic partnership.

Building on a successful collaboration established in 2023, Welldoc is now formally recognized as a participant in the Built on Databricks program. This strategic collaboration leverages Databricks' powerful Data Intelligence Platform to enhance Welldoc's advanced analytics and proprietary AI within the highly regulated healthcare environment. This integration is designed to deliver greater personalization, improve operational efficiency, and optimize health outcomes for enterprise customers and their populations. The partnership also paves the way for go-to-market opportunities.

This expanded partnership supports the ongoing enhancement of Welldoc's proprietary data intelligence and AI capabilities. By combining this robust foundation with Welldoc's extensive expertise in AI modeling and evidence-based clinical feedback, the company enables delivery of hyper-personalized, real-time digital coaching to individuals living with cardiometabolic conditions. Key advancements from this collaboration include:

• Next-generation AI-driven digital coaching: Utilizing centralized data and evidence-based guidance, Welldoc delivers tailored, in-the-moment support aligned with each user’s unique health needs.
• Advanced multivariate analytics insights: Leveraging ongoing innovation in real-time sensor technology, Welldoc dynamically adapts to a user’s biometrics.
• Refined analytical models: Supporting individualized journeys and predictive insights, Welldoc’s models empower proactive and preventive care for users.

“Our expanded partnership with Databricks represents a significant advancement in our mission to deliver personalized, impactful cardiometabolic care within the rigorous standards of a regulated industry,” said Dr. Anand Iyer, Chief AI Officer at Welldoc. “Advanced data intelligence is critical for our customers as we continue to push the boundaries of AI-driven digital health. The Databricks Data Intelligence Platform enables us to seamlessly aggregate Welldoc’s health data and build powerful AI models, driving increased personalization and efficiency across the care continuum.”

“Welldoc is a pioneer in applying AI to solve complex cardiometabolic health challenges within the rigorous standards of a regulated industry. Welldoc’s AI-driven digital coaching is a perfect example of the future of healthcare in action,” said Michael Sanky, VP, Industry GTM Leader, Healthcare and Life Sciences at Databricks. “By building on the Databricks Data Intelligence Platform, Welldoc can unify all their data, from clinical evidence to real-time biometrics, delivering hyper-personalized interventions at scale with FDA-cleared solutions. We are proud that they have chosen the Databricks Data Intelligence Platform as the foundation and look forward to the growing partnership.”

The Databricks Data Intelligence Platform democratizes access to analytics and intelligent applications by uniting customer data with powerful AI models, tailored to the unique characteristics of their organization and industry. More than 60% of the Fortune 500 and hundreds of healthcare leaders trust Databricks with their most sensitive data. Databricks is built on a lakehouse foundation of open data formats, complete with unified data governance to democratize access to everyone, and backed by controls for HIPAA, HITRUST, and GDPR to support the most important standards in the industry.

This enhanced partnership is now available. Learn more about Welldoc's partnership with Databricks in their recent blog. Learn more about the Databricks Built on Partner Program here.

About Welldoc

Welldoc®, a digital health leader revolutionizing cardiometabolic care, integrates personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, facilitating improved health and outcomes. Welldoc’s comprehensive digital health platform offers AI-powered digital coaching for pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental well-being and sleep support. As a FDA-cleared digital health solution, Welldoc guides individuals through the complex journey of living with diabetes, enabling self-management while enhancing connections with their healthcare team. The company partners with health plans, health systems and employers to extend care, improve health and reduce costs.

Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform and holds an IP portfolio of 50+ patents for its advanced AI and first-in-class technology. With more than 90 clinical publications, Welldoc has built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Recognized as an industry thought leader, Welldoc has been featured in prestigious conferences and publications, including South by Southwest, the Wall Street Journal and the Economist. The company has been named the “Best Overall Digital Health Company” by MedTech Breakthrough for the past three years, and was a winner of the 2024 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group, and Top 100 Healthcare Technology Companies by the Healthcare Technology Report. For more information, visit www.welldoc.com. Follow us on LinkedIn and X.